Liver Lineup: Closing the Gap in Women’s Liver Health
In this episode of Liver Lineup , hosts Nancy Reau, MD, and Kimberly Brown, MD, are joined by Meena Bansal, MD, to examine how liver disease uniquely affects women across the lifespan. While conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) are often discussed in broad terms, the trio highlights how risk, progression, and outcomes can differ significantly based on sex and hormonal status. From reproductive years through menopause and beyond, physiologic changes play a central role in shaping liver health, but these distinctions have historically been underrecognized in both research and clinical care. Key Episode Timestamps 0:00:00 – Welcome & women’s liver health framework 0:03:17 – Menopause, estrogen loss, and fibrosis risk 0:10:57 – PCOS, young women, and high‑risk metabolic phenotypes 0:13:54 – Pregnancy, MASH, and maternal-fetal outcomes 0:18:45 – Screening strategy, menopause as a pivot, and intervals 0:28:03 – Practical toolkit: FIB‑4, second‑line tests, and who to test 0:31:27 – Management, GLP‑1s, resmetirom, and key takeaways https://www.hcplive.com/view/liver-lineup-closing-the-gap-in-women-s-liver-health